Subscribe for email alerts

Don’t miss a single Science & Enterprise post. Sign up for our daily email alerts.

Please share Science & Enterprise

AI Analysis Finds Serious Covid-19 Genetic Driver

Network graphic

A deep and multi-variable analysis of patients with serious Covid-19 respiratory symptoms finds the condition associated with abnormal expression of one gene. . . . → Read More: AI Analysis Finds Serious Covid-19 Genetic Driver

AI-Designed Antibodies for Start-Up Sought in Open Call

Computational biology illustration

An international consortium is seeking teams of scientists using algorithms to design new therapeutic antibodies, to form and fund a start-up company. . . . → Read More: AI-Designed Antibodies for Start-Up Sought in Open Call

European Life Science Venture Fund Raises €472M

Euro investments

A venture capital company raised €472 million ($US 548 million) for investments in life science and medical device start-ups in Europe. . . . → Read More: European Life Science Venture Fund Raises €472M

Crispr Licensed for Eye Disease Gene Therapies

Retinal gene therapy

A developer of inherited eye disease therapies is acquiring rights to the gene editing technology Crispr for treatments that work inside the eyes. . . . → Read More: Crispr Licensed for Eye Disease Gene Therapies

Lab Demonstrates 3-D Printed Tissue, Blood Vessel Implant

Tobacco plants

A biomedical engineering team transplanted into a lab rat synthetic tissue with blood vessels made by three-dimensional printing. . . . → Read More: Lab Demonstrates 3-D Printed Tissue, Blood Vessel Implant

Infographic – Cruising Biotech Index Takes Late Dip

Nasdaq Biotech Index, 3rd qtr 2021

NBI, an indicator of investor sentiment in the industry, continued its choppy climb through most of the third quarter, only to start another decline in late September. . . . → Read More: Infographic – Cruising Biotech Index Takes Late Dip

FDA Halts Off-the-Shelf T-Cell Cancer Trials

Stop sign

The Food and Drug Administration stopped a company’s clinical trials of off-the-shelf engineered T-cells after a patient showed an abnormal chromosomal reaction. . . . → Read More: FDA Halts Off-the-Shelf T-Cell Cancer Trials

Precision Neuroscience Company Starts-Up, Raises $500M

Brain activity graphic

A new company is underway developing more precise therapies for psychiatric and neurodegenerative diseases based on genetics and data science. . . . → Read More: Precision Neuroscience Company Starts-Up, Raises $500M

Partnership Seeks Lower-Cost Protein Drugs

Chemical atom model

A biotechnology enterprise and company aiming to make drugs at lower prices are collaborating on new lower-cost synthetic protein drugs. . . . → Read More: Partnership Seeks Lower-Cost Protein Drugs

Seed Stage Investors Raise $450M for New Fund

Stock market graphic

A venture capital company specializing in financing start-up enterprises at their earliest stages says it raised $450 million for its third venture fund. . . . → Read More: Seed Stage Investors Raise $450M for New Fund